as 02-21-2025 4:00pm EST
Upcoming Earnings Alert:
Get ready for potential market movements as Vericel Corporation VCEL prepares to release earnings report on 27 Feb 2025.
Founded: | 1989 | Country: | United States |
Employees: | N/A | City: | CAMBRIDGE |
Market Cap: | N/A | IPO Year: | 1997 |
Target Price: | $63.29 | AVG Volume (30 days): | 341.7K |
Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 0.07 | EPS Growth: | N/A |
52 Week Low/High: | $39.12 - $63.00 | Next Earning Date: | 02-27-2025 |
Revenue: | $226,844,000 | Revenue Growth: | 22.48% |
Revenue Growth (this year): | 23.08% | Revenue Growth (next year): | 21.58% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
SIEGAL JONATHAN | VCEL | Principal Accounting Officer | Feb 18 '25 | Sell | $56.72 | 1,710 | $96,991.20 | 1,206 | |
MCLAUGHLIN KEVIN F | VCEL | Director | Feb 12 '25 | Sell | $55.45 | 7,000 | $388,250.00 | 11,900 | |
SIEGAL JONATHAN | VCEL | Principal Accounting Officer | Feb 5 '25 | Sell | $61.99 | 1,092 | $67,693.08 | 1,206 | |
ZERBE ROBERT L MD | VCEL | Director | Feb 5 '25 | Sell | $62.50 | 2,500 | $156,250.00 | 26,595 | |
SIEGAL JONATHAN | VCEL | Principal Accounting Officer | Jan 28 '25 | Sell | $61.99 | 3,908 | $242,256.92 | 1,206 | |
Wotton Paul K | VCEL | Director | Dec 4 '24 | Sell | $58.72 | 2,600 | $152,672.00 | 27,402 | |
Hopper Jonathan Mark | VCEL | Chief Medical Officer | Dec 2 '24 | Sell | $58.72 | 10,000 | $587,200.00 | 58,371 |
VCEL Breaking Stock News: Dive into VCEL Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 days ago
Argus Research
4 days ago
GlobeNewswire
10 days ago
Argus Research
18 days ago
Argus Research
25 days ago
Argus Research
a month ago
MT Newswires
a month ago
GlobeNewswire
a month ago
The information presented on this page, "VCEL Vericel Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.